SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
1-Year Return
4.68%
This Quarter Return
+10.95%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$629M
AUM Growth
+$97.2M
(+18%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
65.36%
Holding
29
New
3
Increased
8
Reduced
9
Closed
3
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$18.1M |
| 2 |
Perrigo
PRGO
|
$16.4M |
| 3 |
Abbott
ABT
|
$15.2M |
| 4 |
Labcorp
LH
|
$12M |
| 5 |
Elevance Health
ELV
|
$10.6M |
Top Sells
| 1 |
Merck
MRK
|
$16.7M |
| 2 |
Exelixis
EXEL
|
$7.76M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.32M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.93M |
| 5 |
United Therapeutics
UTHR
|
$5.28M |
Sector Composition
| 1 | Healthcare | 98.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
United Therapeutics
UTHR
$17.4B
| $3.92M | 0.62% |
28,974
-39,000
| -57% | -$5.28M |
|
|
27
Exelixis
EXEL
$10.1B
| – | – |
-520,091
| Closed | -$7.76M |
|
|
28
Merck
MRK
$211B
| – | – |
-297,014
| Closed | -$16.7M |
|
|
ALXN
29
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-48,500
| Closed | -$5.93M |
|